Table 2.
Outcome | Age group | Total | ||||
---|---|---|---|---|---|---|
5–14 (42) | 15–24 (29) | 25–34 (29) | 35–44 (16) | ≥45 (14) | ||
No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | |
ETF | 0 | 0 | 0 | 0 | 0 | 0 |
LCF | 0 | 0 | 0 | 0 | 0 | 0 |
LPF | 0 | 0 | 1 (0.8) | 0 | 1 (0.8) | 2 (1.56) |
ACPR | 42 (100) | 29 (100) | 28 (99.2) | 16 (100) | 13 (99.2) | 128 (98.4) |
Total analysis | 42 | 29 | 29 | 16 | 14 | 130 |
Withdrew | 2 | 0 | 2 | 0 | 5 | |
Total | 44 | 29 | 29 | 18 | 14 | 134 |
ETF Early treatment failure, LCF Late clinical failure, LPF Late parasitological failure, ACPR Adequate clinical and parasitological response, With withdrew, No Number, % percent